Skip to main content
OpenTrials

Clinical trial condition

Sexually Transmitted Diseases, Viral

Explore clinical trials studying Sexually Transmitted Diseases, Viral. Study availability and eligibility vary by location and protocol.

6,138 public trials 362 recruiting studies
Refine in advanced search Browse all conditions

Sexually Transmitted Diseases, Viral trial results

Completed

Tipranavir/Ritonavir vs. Genotypically Defined Protease Inhibitor/Ritonavir in HIV Patients (RESIST-2)

NCT00144170

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • 1182.48.5401 Fundación Huésped Buenos Aires, Argentina
  • 1182.48.5402 Fundación Huésped Buenos Aires, Argentina
  • 1182.48.5403 Servicio de Infecciosas Buenos Aires, Argentina
  • 1182.48.5404 Servicio de Infecciosas Buenos Aires, Argentina
View all 174 locations
View Trial Details
Completed

Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST)

NCT00054717

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • 1182.12.62 Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
  • 1182.12.108 El Rio SIA Tucson, Arizona, United States
  • 1182.12.9 Boehringer Ingelheim Investigational Site Berkeley, California, United States
  • 1182.12.23 Boehringer Ingelheim Investigational Site Beverly Hills, California, United States
View all 117 locations
View Trial Details
Completed

Non-interventional Observational Study With Viramune (Nevirapine) and Various Drug Combinations in the Antiretroviral Combination Treatment of HIV-infected Patients Who Have Already Been Treated for Approx. 10 Years With Viramune

NCT00979420

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Boehringer Ingelheim Investigational Site 1 Aachen, Germany
  • Boehringer Ingelheim Investigational Site 10 Berlin, Germany
  • Boehringer Ingelheim Investigational Site 11 Berlin, Germany
  • Boehringer Ingelheim Investigational Site 12 Berlin, Germany
View all 60 locations
View Trial Details
Completed

A Study of TMC278 in Human Immunodeficiency Virus Type 1 Infected Patients, Who Are Not Treated With Antiretroviral Medicines

NCT00110305

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Beverly Hills, California, United States
  • Washington D.C., District of Columbia, United States
  • Orlando, Florida, United States
  • Tampa, Florida, United States
View all 40 locations
View Trial Details

Related conditions